×
About 1,617 results

ALLMedicine™ Infectious Diarrhea Center

Research & Reviews  493 results

What Is the Efficacy of Probiotics for the Treatment of Acute Infectious Diarrhea?
https://doi.org/10.1016/j.annemergmed.2021.02.005
Annals of Emergency Medicine; Gottlieb M, Mogni B et. al.

May 1st, 2021 - What Is the Efficacy of Probiotics for the Treatment of Acute Infectious Diarrhea?|2021|Gottlieb M,Mogni B,Ramsay N,|

Effectiveness of probiotics and synbiotics in reducing duration of acute infectious dia...
https://doi.org/10.1007/s00431-021-04046-7 10.1038/nrgastro.2014.66 10.3920/BM2017.0183 10.3748/wjg.v24.i41.4652 10.1007/s00253-019-09978-7 10.1097/MPG.0000000000000375 10.1542/peds.2009-3270 10.1097/MPG.0000000000000320 10.1111/apa.13432 10.1371/journal.pmed.1000097 10.3109/07388551.2014.953443 10.5281/zenodo.2551803 10.1136/bmjopen-2015-010247 10.1002/jrsm.11 10.1002/sim.1221 10.1002/jrsm.12 10.1002/sim.791 10.1002/sim.1262 10.1016/j.csda.2005.07.019 10.1186/1471-2288-14-25 10.1002/jrsm.1164 10.1080/10705511.2016.1186549 10.1007/BF02087695 10.1097/00005176-199704000-00008 10.1097/00006454-199712000-00002 10.1097/00005176-199711000-00005 10.1097/00005176-200001000-00018 10.1097/01.inf.0000014470.82881.25 10.1097/01.inf.0000014471.82190.59 10.1097/INF.0b013e3181b530bf 10.1097/PEC.0b013e31826cad9f 10.1016/j.clinre.2014.09.006 10.1056/NEJMoa1802597 10.1056/NEJMoa1802598 10.1111/j.1365-2036.2011.04835.x 10.1111/j.1365-2036.2012.05015.x 10.1186/1471-2288-14-135 10.1177/0962280216669183 10.1186/s12874-018-0483-0 10.1093/cid/ciu065 10.1111/apt.13590 10.3390/nu10081074 10.1007/s40272-015-0124-6 10.1097/MOG.0000000000000132 10.11569/wcjd.v25.i27.2486 10.3390/nu10091189 10.1111/apt.13740 10.1097/INF.0000000000002355 10.1038/s41591-019-0439-x 10.7326/M18-0343 10.7326/M18-0343 10.7326/M18-0343 10.1002/14651858.CD003048.pub3 10.1002/ebch.1932 10.1371/journal.pone.0128754 10.1039/c8fo00376a 10.1002/14651858.ED000075 10.1002/14651858.ED000076 10.1097/MOP.0000000000000808
European Journal of Pediatrics; Vassilopoulou L, Spyromitrou-Xioufi P et. al.

Apr 7th, 2021 - Acute diarrhea is one of the most frequent causes of doctor visits and hospital admissions for children. Our objective was to evaluate the association between probiotics administration and reduction of acute infectious diarrhea duration in childre...

Quinolone resistant Salmonella species isolated from pediatric patients with diarrhea i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010990
BMC Gastroenterology; Abbasi E, Ghaznavi-Rad E

Mar 31st, 2021 - This study aimed to investigate the frequency and the antibiotic resistance patterns of Salmonella species that were isolated from infectious diarrhea samples taken from pediatric patients in central Iran. The study analyzed 230 stool specimens th...

Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut p...
https://doi.org/10.1038/s41385-021-00386-7 10.1097/01.mcg.0000177231.13770.07 10.1093/femspd/ftw111 10.3892/mmr.2014.1898 10.1016/j.immuni.2005.09.015 10.1371/journal.pone.0003331 10.1038/nrd2660 10.3389/fimmu.2017.00475 10.1016/j.celrep.2016.04.049 10.1038/nri2692 10.2119/molmed.2011.00428 10.1038/s41385-019-0176-y 10.1016/j.immuni.2015.06.006 10.4049/jimmunol.1800292 10.1038/nm1720 10.1111/j.1462-5822.2005.00625.x 10.1038/s41385-019-0153-5 10.4049/jimmunol.178.5.2661 10.1016/j.immuni.2008.11.009 10.1016/j.immuni.2015.08.019 10.1038/nri3608 10.1136/gutjnl-2011-301785 10.1016/j.jcmgh.2019.02.006 10.1172/JCI88625 10.3389/fimmu.2015.00639 10.1038/nature13577 10.1038/mi.2014.17 10.1016/j.cell.2015.08.058 10.1007/s10875-010-9368-7 10.1016/j.immuni.2015.09.003 10.4049/jimmunol.1303076 10.1016/j.it.2012.01.003 10.1007/s10157-018-1675-y 10.1038/s41385-019-0138-4 10.1016/j.molimm.2017.11.020 10.1038/s41467-019-10733-9 10.1016/j.chom.2019.03.003 10.1084/jem.20061852 10.1073/pnas.1424236112 10.1126/science.1160062 10.1084/jem.191.6.1069 10.1073/pnas.1003059107 10.3389/fimmu.2019.01386 10.1186/1746-6148-9-123 10.1371/journal.ppat.1006649 10.1158/0008-5472.CAN-13-3065
Mucosal Immunology; Palmieri V, Ebel JF et. al.

Mar 3rd, 2021 - A wide range of microbial pathogens is capable of entering the gastrointestinal tract, causing infectious diarrhea and colitis. A finely tuned balance between different cytokines is necessary to eradicate the microbial threat and to avoid infectio...

Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infec...
https://doi.org/10.1128/IAI.00041-21 10.1016/S1473-3099(18)30362-1 10.1016/S2214-109X(18)30483-2 10.1016/j.vaccine.2017.09.083 10.1016/S1473-3099(18)30546-2 10.1016/j.ebiom.2016.07.030 10.1016/j.vaccine.2017.10.011 10.1093/infdis/jiy312 10.1128/IAI.23.3.729-736.1979 10.1016/S0140-6736(03)13971-2 10.1128/IAI.00459-07 10.1016/0966-842x(96)10068-8 10.1128/mSphere.00215-18 10.1007/s11908-019-0665-x 10.1080/21645515.2018.1496768 10.1128/IAI.01225-15 10.1038/s41598-017-03631-x 10.1016/j.vaccine.2019.01.016 10.1038/s41541-019-0131-7 10.1371/journal.pntd.0007825 10.1128/IAI.74.4.2245-2258.2006 10.1128/iai.72.3.1786-1794.2004 10.1371/journal.pntd.0003446 10.1128/IAI.01078-13 10.1128/CVI.00248-16 10.1016/j.vaccine.2009.05.076 10.1128/IAI.01304-07 10.1111/mmi.12044 10.1128/IAI.01856-06 10.1128/CDLI.8.3.482-488.2001 10.1016/S0140-6736(88)90284-X 10.1086/657085 10.1016/j.vaccine.2017.05.005 10.1016/j.diagmicrobio.2007.09.010 10.1086/427662 10.1074/jbc.M111.251546 10.1038/nature07568 10.1128/JB.00710-10 10.1016/S0140-6736(13)60844-2 10.1016/S2214-109X(15)00151-5 10.1002/path.1700710126 10.1093/infdis/130.6.595 10.1093/infdis/123.4.378 10.1128/IAI.00264-10 10.1172/JCI97659 10.1093/cid/cis238 10.1016/j.vaccine.2019.03.040 10.1128/mBio.00501-15 10.7717/peerj.332 10.1073/pnas.1306836110 10.1371/journal.pone.0054287 10.1093/bioinformatics/btq461 10.1186/1741-7007-4-41 10.1093/bioinformatics/btq167 10.4056/sigs.1223234 10.1186/1471-2105-6-2 10.1093/bioinformatics/btq249 10.1093/bioinformatics/bti822 10.1110/ps.03479604 10.1073/pnas.0408782102 10.1093/clinchem/26.9.1255
Infection and Immunity; Kuhlmann FM, Laine RO et. al.

Feb 9th, 2021 - Enterotoxigenic Escherichia coli (ETEC) contributes significantly to the substantial burden of infectious diarrhea among children living in low- and middle-income countries. In the absence of a vaccine for ETEC, children succumb to acute dehydrati...

see more →

Guidelines  5 results

Diagnosing Infectious Diarrhea Using Molecular Panels
https://labtestsonline.org/news/diagnosing-infectious-diarrhea-using-molecular-panels
American Association of Clinical Chemists

Mar 20th, 2018 - The Infectious Diseases Society of America (IDSA) published an update to their 2001 guidelines on the diagnosis and management of infectious diarrhea in a recent issue of Clinical Infectious Diseases. For the first time, the guidelines include rec.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagno...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848254
Clinical Infectious Diseases : an Official Publication Of... Shane AL, Mody RK et. al.

Dec 1st, 2017 - These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea. They are not intended to replace physician judgement regarding specific patients or clinical or pub...

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis a...
https://academic.oup.com/cid/article/65/12/e45/4557073
Andi L Shane

Nov 28th, 2017 - The following evidence-based guidelines for management of infants, children, adolescents, and adults in the United States with acute or persistent infectious diarrhea were prepared by an expert panel assembled by the Infectious Diseases Society of.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagno...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850553
Clinical Infectious Diseases : an Official Publication Of... Shane AL, Mody RK et. al.

Oct 20th, 2017 - These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea. They are not intended to replace physician judgement regarding specific patients or clinical or pub...

Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults
https://gi.org/guideline/diagnosis-treatment-and-prevention-of-acute-diarrheal-infections-in-adults/
Mark S. Riddle

Apr 11th, 2016 - Acute diarrheal infections are a common health problem globally and among both individuals in the United States and traveling to developing world countries. Multiple modalities including antibiotic and non-antibiotic therapies have been used to ad.

see more →

Drugs  279 results see all →

Clinicaltrials.gov  811 results

Ciprofloxacin - ciprofloxacin tablet, film coated-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62cb8a94-05a3-48e4-9b51-4ff0e2a72f10

May 2nd, 2021 - Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: • Skin and Skin Structure...

What Is the Efficacy of Probiotics for the Treatment of Acute Infectious Diarrhea?
https://doi.org/10.1016/j.annemergmed.2021.02.005
Annals of Emergency Medicine; Gottlieb M, Mogni B et. al.

May 1st, 2021 - What Is the Efficacy of Probiotics for the Treatment of Acute Infectious Diarrhea?|2021|Gottlieb M,Mogni B,Ramsay N,|

Ciprofloxacin - ciprofloxacin tablet-American Health Packaging
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4be79d58-1436-44c2-9b3a-836c6e4f1c67

Apr 29th, 2021 - Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections...

Ciprofloxacin - ciprofloxacin tablet-DRUG OCEAN LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2457520c-ff99-415b-a640-83bae2aa4586

Apr 25th, 2021 - Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections...

Ciprofloxacin - ciprofloxacin tablet, film coated-QPharma Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0e0da3c-31d6-e742-e053-2a95a90a2165

Apr 22nd, 2021 - Ciprofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Inf...

see more →

News  29 results

Fast Five Quiz: Norovirus
https://reference.staging.medscape.com/viewarticle/937432_6

Sep 21st, 2020 - Oral fluids and electrolyte replacement are generally adequate for the treatment of norovirus infections. In cases of severe volume depletion, intravenous fluid and electrolyte resuscitation may be necessary. Symptomatic relief can be achieved usi...

Alarm Raised on Safety of Commercial Probiotics
https://www.medpagetoday.com/primarycare/dietnutrition/75159

Sep 18th, 2018 - The mass marketing of unregulated probiotics for general human health is coming under fire. Despite some benefit of selected strains in defined gastrointestinal contexts such as post-infectious diarrhea, post-colectomy pouchitis, and remission mai...

IDSA updates infectious diarrhea guidelines
https://www.mdedge.com/gihepnews/article/150494/pediatrics/idsa-updates-infectious-diarrhea-guidelines
Amy Karon, MDedge News

Oct 27th, 2017 - Molecular-based diagnostic tests for enteric pathogens are highly sensitive but may require expert input to assess their clinical and public health implications, according to new guidelines from the Infectious Diseases Society of America. Among th.

Synthetic Biologics' C. difficile mid-stage study meets main goal
https://www.reuters.com/article/us-synthetic-study/synthetic-biologics-c-difficile-mid-stage-study-meets-main-goal-idUSKBN14P1C2

Jan 5th, 2017 - (Reuters) - Synthetic Biologics Inc said its experimental treatment designed to reduce antibiotic-resistant “superbug” infections - notably life-threatening C. difficile - outperformed a placebo in a trial. The company’s oral enzyme, ribaxamase, m...

see more →